Suven Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals) has submitted a certificate to the Exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing related to the company's depository participation. The announcement does not disclose any material financial figures or corporate action. Such filings are typically part of the company's ongoing compliance obligations with SEBI and the exchanges.
This is a routine regulatory filing with no direct impact on shareholders' value or stock price. It signals continued compliance with SEBI depository regulations and does not indicate any corporate action, dividend, or strategic change.